Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.9K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.6K
3.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.1K
3.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

12.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.6K
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of the catastrophic medical insurance on household catastrophic health expenditure: evidence from China.

Gaceta sanitaria·2019
Same author

Cancer therapy with a CRISPR-assisted telomerase-activating gene expression system.

Oncogene·2019
Same author

Ferroptosis as a target for protection against cardiomyopathy.

Proceedings of the National Academy of Sciences of the United States of America·2019
Same author

Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis.

Medical science monitor : international medical journal of experimental and clinical research·2019
Same author

Normative pattern and determinants of outer retinal thickness in an Asian population: the Singapore Epidemiology of Eye Diseases Study.

The British journal of ophthalmology·2019
Same author

Association of Diabetes With Central Corneal Thickness Among a Multiethnic Asian Population.

JAMA network open·2019

Related Experiment Video

Updated: Apr 19, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

10.7K

Genomic Instability and Cancer.

Yixin Yao1, Wei Dai2

  • 1Department of Environmental Medicine, New York University Langone Medical Center, Tuxedo, New York, 10987, USA.

Journal of Carcinogenesis & Mutagenesis
|December 27, 2014
PubMed
Summary

Genomic instability, a hallmark of cancer, arises from defects in DNA repair and cell cycle checkpoints. This summary explores how epigenetic factors like histone modifications and DNA methylation influence genome stability and cancer development.

More Related Videos

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence
06:25

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence

Published on: February 10, 2023

2.6K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.3K

Related Experiment Videos

Last Updated: Apr 19, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

10.7K
Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence
06:25

Quantifying Replication Stress in Ovarian Cancer Cells Using Single-Stranded DNA Immunofluorescence

Published on: February 10, 2023

2.6K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.3K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Genomic instability, characterized by increased genome alteration, is prevalent in cancer cells.
  • Cancer often arises from damage to genes regulating cell division and tumor suppressors.
  • Genomic integrity is maintained by surveillance mechanisms including DNA damage and mitotic checkpoints.

Purpose of the Study:

  • To summarize recent advancements in understanding genomic instability.
  • To discuss the role of epigenetic modifications in maintaining genomic integrity.
  • To explore the contribution of genomic instability to tumor initiation and progression.

Main Methods:

  • Literature review of recent developments in cancer genomics and epigenetics.
  • Analysis of the interplay between DNA repair, cell cycle checkpoints, and epigenetic regulation.
  • Discussion of the debate surrounding the driving forces of tumor initiation and progression.

Main Results:

  • Defects in surveillance mechanisms (DNA damage, mitotic checkpoints, DNA repair) lead to genomic instability.
  • Posttranslational histone modifications and DNA methylation status are linked to cell cycle regulation and chromatin structure.
  • Epigenetic alterations play a significant role in predisposing cells to malignant transformation.

Conclusions:

  • Genomic instability is a critical factor in cancer development.
  • Epigenetic modifications are key regulators of genomic integrity and cancer progression.
  • Further research into these mechanisms is crucial for understanding tumor initiation and developing targeted therapies.